Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
DexCom, Inc.
About DXCM
DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. It enables people to take control of health through innovative biosensing technology. The G7 is an integrated continuous glucose monitoring system. Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes. The G7 and G7 15 Day includes finger stick elimination, continuous glucose readings and others.
Find out what a historical investment in DexCom, Inc. would be worth today using our DXCM stock calculator.
Market Capitalisation
$23.78B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
11.13M
High today
$63.19
Low today
$59.46
Open price
$59.91
52-week high
$89.98
52-week low
$54.11
Ready to start your investing journey with Stake?
Open an accountHow do I buy DXCM shares in Australia?
Buying DXCM shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in DexCom, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in DXCM
What is the ticker symbol of DexCom, Inc.?
The ticker symbol for DexCom, Inc. is DXCM.
How much is one share of DXCM?
One share of DXCM is valued at $61.53 as of 16 May 2026.
What is the market capitalisation of DexCom, Inc. DXCM?
As of 16 May 2026 DexCom, Inc. has a market cap of $23.78B.
What is the P/E ratio of DXCM?
The Price to Earnings ratio of DXCM is 24.94.
What is the Earnings Per Share of DXCM?
The Earnings Per Share of DXCM is $2.32.
What is the 52-week high for DexCom, Inc. stock?
The DexCom, Inc. 52-week high stock price is $89.98.
What is the 52-week low for DexCom, Inc. stock?
The DexCom, Inc. 52-week low stock price is $54.11.
Can I buy DXCM shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy DXCM shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in DXCM on Stake
- Buy DXCM from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of DXCM from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
DXCM related stocks